TrialAnnals of surgical oncology2016

KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.

Oliver S Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.